Report Detail

Pharma & Healthcare Global Next Generation Cancer Treatment Market Growth (Status and Outlook) 2022-2028

  • RnM4495270
  • |
  • 15 November, 2022
  • |
  • Global
  • |
  • 101 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Next Generation Cancer Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Next Generation Cancer Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Next Generation Cancer Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Next Generation Cancer Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Next Generation Cancer Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Next Generation Cancer Treatment players cover OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., GlaxoSmithKline plc and Boehringer Ingelheim GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Next Generation Cancer Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Next Generation Cancer Treatment market, with both quantitative and qualitative data, to help readers understand how the Next Generation Cancer Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Next Generation Cancer Treatment market and forecasts the market size by Type (CAR-T Therapy, Targeted Cancer Therapy and Others), by Application (Lung Cancer, Colorectal Cancer, Stomach Cancer and Breast Cancer), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
CAR-T Therapy
Targeted Cancer Therapy
Others

Segmentation by application
Lung Cancer
Colorectal Cancer
Stomach Cancer
Breast Cancer
Liver Cancer
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
Walking Fish Therapeutics
Kojin Therapeutics
Scorpion Therapeutics

Chapter Introduction
Chapter 1: Scope of Next Generation Cancer Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Next Generation Cancer Treatment market size and CAGR, Next Generation Cancer Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Next Generation Cancer Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Next Generation Cancer Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Next Generation Cancer Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Bayer HealthCare AG, Abbott Laboratories, Walking Fish Therapeutics and Kojin Therapeutics, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Next Generation Cancer Treatment Market Size 2017-2028
    • 2.1.2 Next Generation Cancer Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Next Generation Cancer Treatment Segment by Type
    • 2.2.1 CAR-T Therapy
    • 2.2.2 Targeted Cancer Therapy
    • 2.2.3 Others
  • 2.3 Next Generation Cancer Treatment Market Size by Type
    • 2.3.1 Next Generation Cancer Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Next Generation Cancer Treatment Market Size Market Share by Type (2017-2022)
  • 2.4 Next Generation Cancer Treatment Segment by Application
    • 2.4.1 Lung Cancer
    • 2.4.2 Colorectal Cancer
    • 2.4.3 Stomach Cancer
    • 2.4.4 Breast Cancer
    • 2.4.5 Liver Cancer
    • 2.4.6 Others
  • 2.5 Next Generation Cancer Treatment Market Size by Application
    • 2.5.1 Next Generation Cancer Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Next Generation Cancer Treatment Market Size Market Share by Application (2017-2022)

3 Next Generation Cancer Treatment Market Size by Player

  • 3.1 Next Generation Cancer Treatment Market Size Market Share by Players
    • 3.1.1 Global Next Generation Cancer Treatment Revenue by Players (2020-2022)
    • 3.1.2 Global Next Generation Cancer Treatment Revenue Market Share by Players (2020-2022)
  • 3.2 Global Next Generation Cancer Treatment Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Next Generation Cancer Treatment by Regions

  • 4.1 Next Generation Cancer Treatment Market Size by Regions (2017-2022)
  • 4.2 Americas Next Generation Cancer Treatment Market Size Growth (2017-2022)
  • 4.3 APAC Next Generation Cancer Treatment Market Size Growth (2017-2022)
  • 4.4 Europe Next Generation Cancer Treatment Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Next Generation Cancer Treatment Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Next Generation Cancer Treatment Market Size by Country (2017-2022)
  • 5.2 Americas Next Generation Cancer Treatment Market Size by Type (2017-2022)
  • 5.3 Americas Next Generation Cancer Treatment Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Next Generation Cancer Treatment Market Size by Region (2017-2022)
  • 6.2 APAC Next Generation Cancer Treatment Market Size by Type (2017-2022)
  • 6.3 APAC Next Generation Cancer Treatment Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Next Generation Cancer Treatment by Country (2017-2022)
  • 7.2 Europe Next Generation Cancer Treatment Market Size by Type (2017-2022)
  • 7.3 Europe Next Generation Cancer Treatment Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Next Generation Cancer Treatment by Region (2017-2022)
  • 8.2 Middle East & Africa Next Generation Cancer Treatment Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Next Generation Cancer Treatment Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Next Generation Cancer Treatment Market Forecast

  • 10.1 Global Next Generation Cancer Treatment Forecast by Regions (2023-2028)
    • 10.1.1 Global Next Generation Cancer Treatment Forecast by Regions (2023-2028)
    • 10.1.2 Americas Next Generation Cancer Treatment Forecast
    • 10.1.3 APAC Next Generation Cancer Treatment Forecast
    • 10.1.4 Europe Next Generation Cancer Treatment Forecast
    • 10.1.5 Middle East & Africa Next Generation Cancer Treatment Forecast
  • 10.2 Americas Next Generation Cancer Treatment Forecast by Country (2023-2028)
    • 10.2.1 United States Next Generation Cancer Treatment Market Forecast
    • 10.2.2 Canada Next Generation Cancer Treatment Market Forecast
    • 10.2.3 Mexico Next Generation Cancer Treatment Market Forecast
    • 10.2.4 Brazil Next Generation Cancer Treatment Market Forecast
  • 10.3 APAC Next Generation Cancer Treatment Forecast by Region (2023-2028)
    • 10.3.1 China Next Generation Cancer Treatment Market Forecast
    • 10.3.2 Japan Next Generation Cancer Treatment Market Forecast
    • 10.3.3 Korea Next Generation Cancer Treatment Market Forecast
    • 10.3.4 Southeast Asia Next Generation Cancer Treatment Market Forecast
    • 10.3.5 India Next Generation Cancer Treatment Market Forecast
    • 10.3.6 Australia Next Generation Cancer Treatment Market Forecast
  • 10.4 Europe Next Generation Cancer Treatment Forecast by Country (2023-2028)
    • 10.4.1 Germany Next Generation Cancer Treatment Market Forecast
    • 10.4.2 France Next Generation Cancer Treatment Market Forecast
    • 10.4.3 UK Next Generation Cancer Treatment Market Forecast
    • 10.4.4 Italy Next Generation Cancer Treatment Market Forecast
    • 10.4.5 Russia Next Generation Cancer Treatment Market Forecast
  • 10.5 Middle East & Africa Next Generation Cancer Treatment Forecast by Region (2023-2028)
    • 10.5.1 Egypt Next Generation Cancer Treatment Market Forecast
    • 10.5.2 South Africa Next Generation Cancer Treatment Market Forecast
    • 10.5.3 Israel Next Generation Cancer Treatment Market Forecast
    • 10.5.4 Turkey Next Generation Cancer Treatment Market Forecast
    • 10.5.5 GCC Countries Next Generation Cancer Treatment Market Forecast
  • 10.6 Global Next Generation Cancer Treatment Forecast by Type (2023-2028)
  • 10.7 Global Next Generation Cancer Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 OncoGenex Pharmaceuticals, Inc.
    • 11.1.1 OncoGenex Pharmaceuticals, Inc. Company Information
    • 11.1.2 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Product Offered
    • 11.1.3 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 OncoGenex Pharmaceuticals, Inc. Main Business Overview
    • 11.1.5 OncoGenex Pharmaceuticals, Inc. Latest Developments
  • 11.2 Cytokinetics Inc.
    • 11.2.1 Cytokinetics Inc. Company Information
    • 11.2.2 Cytokinetics Inc. Next Generation Cancer Treatment Product Offered
    • 11.2.3 Cytokinetics Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Cytokinetics Inc. Main Business Overview
    • 11.2.5 Cytokinetics Inc. Latest Developments
  • 11.3 Hospira Inc.
    • 11.3.1 Hospira Inc. Company Information
    • 11.3.2 Hospira Inc. Next Generation Cancer Treatment Product Offered
    • 11.3.3 Hospira Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Hospira Inc. Main Business Overview
    • 11.3.5 Hospira Inc. Latest Developments
  • 11.4 GlaxoSmithKline plc
    • 11.4.1 GlaxoSmithKline plc Company Information
    • 11.4.2 GlaxoSmithKline plc Next Generation Cancer Treatment Product Offered
    • 11.4.3 GlaxoSmithKline plc Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 GlaxoSmithKline plc Main Business Overview
    • 11.4.5 GlaxoSmithKline plc Latest Developments
  • 11.5 Boehringer Ingelheim GmbH
    • 11.5.1 Boehringer Ingelheim GmbH Company Information
    • 11.5.2 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Product Offered
    • 11.5.3 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Boehringer Ingelheim GmbH Main Business Overview
    • 11.5.5 Boehringer Ingelheim GmbH Latest Developments
  • 11.6 Bayer HealthCare AG
    • 11.6.1 Bayer HealthCare AG Company Information
    • 11.6.2 Bayer HealthCare AG Next Generation Cancer Treatment Product Offered
    • 11.6.3 Bayer HealthCare AG Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Bayer HealthCare AG Main Business Overview
    • 11.6.5 Bayer HealthCare AG Latest Developments
  • 11.7 Abbott Laboratories
    • 11.7.1 Abbott Laboratories Company Information
    • 11.7.2 Abbott Laboratories Next Generation Cancer Treatment Product Offered
    • 11.7.3 Abbott Laboratories Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Abbott Laboratories Main Business Overview
    • 11.7.5 Abbott Laboratories Latest Developments
  • 11.8 Walking Fish Therapeutics
    • 11.8.1 Walking Fish Therapeutics Company Information
    • 11.8.2 Walking Fish Therapeutics Next Generation Cancer Treatment Product Offered
    • 11.8.3 Walking Fish Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Walking Fish Therapeutics Main Business Overview
    • 11.8.5 Walking Fish Therapeutics Latest Developments
  • 11.9 Kojin Therapeutics
    • 11.9.1 Kojin Therapeutics Company Information
    • 11.9.2 Kojin Therapeutics Next Generation Cancer Treatment Product Offered
    • 11.9.3 Kojin Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Kojin Therapeutics Main Business Overview
    • 11.9.5 Kojin Therapeutics Latest Developments
  • 11.10 Scorpion Therapeutics
    • 11.10.1 Scorpion Therapeutics Company Information
    • 11.10.2 Scorpion Therapeutics Next Generation Cancer Treatment Product Offered
    • 11.10.3 Scorpion Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Scorpion Therapeutics Main Business Overview
    • 11.10.5 Scorpion Therapeutics Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Next Generation Cancer Treatment. Industry analysis & Market Report on Next Generation Cancer Treatment is a syndicated market report, published as Global Next Generation Cancer Treatment Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Next Generation Cancer Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,030.48
6,060.96
3,517.26
7,034.52
509,618.40
1,019,236.80
299,022.00
598,044.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report